Who are the investors of alder fuels?
Alder Fuels has 2 investors including United Airlines Ventures and Honeywell. How much funding has Alder Fuels raised to date? Alder Fuels has raised —. When was the last funding round for Alder Fuels?
What is alder fuels’ Jet fuel?
Alder Fuels wants to change that. The new clean tech company, headed by Bryan Sherbacow, is developing a low-carbon jet fuel that can be used as a 100% drop-in replacement for petroleum fuel, without needing to adapt existing aircraft or engines.
How much is Alder Biopharmaceuticals stock worth?
One share of ALDR stock can currently be purchased for approximately $18.88. How much money does Alder Biopharmaceuticals make? Alder Biopharmaceuticals has a market capitalization of $1.58 billion and generates $1.62 million in revenue each year.
What does Alder fuels’ deal with United and Honeywell mean?
Alder Fuels said Thursday it has inked a multimillion dollar investment from aviation giants United and Honeywell — as well as a purchase agreement from United for 1.5 billion gallons of fuel, the largest known agreement for SAF in aviation history.
See more
How were Alder Biopharmaceuticals' earnings last quarter?
Alder Biopharmaceuticals Inc (NASDAQ:ALDR) issued its quarterly earnings data on Tuesday, August, 7th. The biopharmaceutical company reported ($1.0...
Who are Alder Biopharmaceuticals' key executives?
Alder Biopharmaceuticals' management team includes the following people: Dr. John A. Latham , Co-Founder & Chief Scientific Officer (Age 59) Mr....
Who are some of Alder Biopharmaceuticals' key competitors?
Some companies that are related to Alder Biopharmaceuticals include Sarepta Therapeutics (SRPT) , Perrigo (PRGO) , Intra-Cellular Therapies (ITC...
What other stocks do shareholders of Alder Biopharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Alder Biopharmaceuticals investors own include NVIDIA (NVD...
What is Alder Biopharmaceuticals' stock symbol?
Alder Biopharmaceuticals trades on the NASDAQ under the ticker symbol "ALDR."
What is Alder Biopharmaceuticals' stock price today?
One share of ALDR stock can currently be purchased for approximately $18.88.
How much money does Alder Biopharmaceuticals make?
Alder Biopharmaceuticals (NASDAQ:ALDR) has a market capitalization of $1.58 billion and generates $1.62 million in revenue each year. The biopharma...
How many employees does Alder Biopharmaceuticals have?
Alder Biopharmaceuticals employs 202 workers across the globe.
What is Alder Biopharmaceuticals' official website?
The official website for Alder Biopharmaceuticals is www.alderbio.com .
Alder Fuels Valuation & Funding
This information is available in the PitchBook Platform. To explore Alder Fuels‘s full profile, request access.
Alder Fuels Investors
This information is available in the PitchBook Platform. To explore Alder Fuels‘s full profile, request access.
How were Alder Biopharmaceuticals' earnings last quarter?
Alder Biopharmaceuticals Inc (NASDAQ:ALDR) released its quarterly earnings data on Tuesday, August, 7th. The biopharmaceutical company reported ($1.04) EPS for the quarter, topping the consensus estimate of ($1.05) by $0.01. View Alder Biopharmaceuticals' earnings history.
Who are some of Alder Biopharmaceuticals' key competitors?
Some companies that are related to Alder Biopharmaceuticals include Ascendis Pharma A/S (ASND), Legend Biotech (LEGN), Arena Pharmaceuticals (ARNA), Zai Lab (ZLAB), Perrigo (PRGO), Evotec (EVTCY), Ultragenyx Pharmaceutical (RARE), HUTCHMED (HCM), Arrowhead Pharmaceuticals (ARWR), Mirati Therapeutics (MRTX), Intra-Cellular Therapies (ITCI), Ionis Pharmaceuticals (IONS), Galapagos (GLPG), Hypera (HYPMY) and ACADIA Pharmaceuticals (ACAD). View all of ALDR's competitors..
What other stocks do shareholders of Alder Biopharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Alder Biopharmaceuticals investors own include NVIDIA (NVDA), AbbVie (ABBV), (CPXX) (CPXX), Micron Technology (MU), (CELG), Gilead Sciences (GILD), Alibaba Group (BABA), Synergy Pharmaceuticals (SGYP), Sarepta Therapeutics (SRPT) and Celldex Therapeutics (CLDX).
What is Alder Biopharmaceuticals' stock symbol?
Alder Biopharmaceuticals trades on the NASDAQ under the ticker symbol "ALDR."
What is Alder Biopharmaceuticals' stock price today?
One share of ALDR stock can currently be purchased for approximately $18.88.
How much money does Alder Biopharmaceuticals make?
Alder Biopharmaceuticals has a market capitalization of $1.58 billion and generates $1.62 million in revenue each year. The biopharmaceutical company earns $-296.43 million in net income (profit) each year or ($4.87) on an earnings per share basis.
What is Alder Biopharmaceuticals' official website?
The official website for Alder Biopharmaceuticals is www.alderbio.com.
Funding
Alder Fuels has raised a total of — in funding over 1 round. This was a Venture - Series Unknown round raised on Sep 9, 2021. Alder Fuels is funded by 2 investors. United Airlines Ventures and Honeywell are the most recent investors.
Funding Rounds
Alder Fuels has raised a total of — in funding over 1 round. This was a Venture - Series Unknown round raised on Sep 9, 2021.
Investors
Alder Fuels is funded by 2 investors. United Airlines Ventures and Honeywell are the most recent investors.
Even Palm makes wireless earbuds now
If you had asked me the other week which consumer electronics companies have yet to get into the wireless earbud business, I probably would have stared at you blankly for a while. Over the past few...
Bridging the gap: What CISOs must do to get the C-suite on their side
Every CISO must face a cold, hard fact: You might not have a seat at the boardroom table or the executive leadership team meeting.
Trillion dollar Tesla
Hark, all ye who pay attention to the stock market, for Elon Musk’s wheels-focused company broached the $1 trillion market cap threshold today. Yeah, it finally happened, so the Equity team q...
Anfield Energy Amends Private Placement Terms
VANCOUVER, British Columbia, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) announces that it has amended the terms of its current non-brokered private placement which was announced on January 11, 2022.
Anfield Energy to Complete a Mineral Resource Report for Four of its West Slope Project Mines
VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Anfield Energy Inc.
Anfield Energy Provides Corporate Update
VANCOUVER, British Columbia, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to provide a corporate update with regard to its operations.